More than survival curves: why every oncologist has to read this article on adaptive hope

When the review by Cherny et al.¹ arrived in this journal, I did something I rarely do with a scientific paper: I shared it with every physician in my department—not as background reading, but as a clinical directive: required reading. Because ‘Hope and despair in cancer and other illness: a clinical framework for adaptive hope across the illness trajectory’¹ reminds us that oncology is far more than survival curves and data points. It is patient-centered care—and at its heart lies communication, including how we communicate about hope.

We—an oncologist, a psycho-oncologist, a neurologist, and a hospital chaplain—wrote this editorial together deliberately, as a multidisciplinary team (MDT). Hope and despair in serious illness are not the province of any one profession. All of us encounter them. All of us are responsible.

What is adaptive hope?

Cherny et al.¹ define adaptive hope as hope that is honest, flexible, and continuously realigned with the patient’s evolving reality and goals—not the hope of denial, nor false reassurance. Hope is not a fixed object but a dynamic process. A patient newly diagnosed may hope for a cure; months later, for attending a daughter’s wedding, maintaining part-time work, or dying at home. Our neurologist described it vividly: a patient with amyotrophic lateral sclerosis who initially refuses noninvasive ventilation may later agree—not because the prognosis changed, but because partly daytime oxygen support would allow them to take a short walk in the afternoon. That is an example of adaptive hope: a shift toward achievable goals that restores agency and meaning.

The danger lies not in hope itself, but in its rigidity. When hope becomes inflexible, it impairs informed decision making and fuels nonbeneficial treatment near the end of life.² Cherny et al.¹ offer the complementary answer: the clinical task is not to extinguish hope but to accompany its transformation.

Tools for the daily work

This article offers concrete tools for conversations every oncologist faces daily—and which, as the European Society of Medical Oncology position paper on supportive and palliative care has consistently emphasized, must be part of oncological training from the outset.³ When a patient with metastatic pancreatic cancer insists she will see her sons grow up, the clinical question is not always how do I correct this, but what does this hope tell me about what matters most to her? The article’s structured tables on hope-fostering strategies are, as one of our group put it, ‘instruments you can actually put in your pocket’—for the junior oncologist who does not know how to respond when a patient prays for a miracle, for the consultant who has to deliver difficult news during a ward round and tries to balance honesty with hope in the time available, and for anyone who has felt that tension between truth and care.

In the chaplain’s daily experience, it is a recurring observation that clinicians entering these conversations carry their own unresolved questions of spirituality and meaning. A physician may find herself recommending a treatment she would not choose for herself, advocating life-prolongation shaped by institutional norms rather than her own deeply held sense of what constitutes a life worth living—and this inner dissonance, if unacknowledged, is precisely what the article identifies as a driver of moral distress, implicit collusion, and the erosion of the therapeutic relationship.

The silence we rarely name: clinician self-care

When clinicians—under time pressure, emotionally depleted, or without adequate training or simply lack the ability—cannot hold honesty and compassion together, they often resort to implicit collusion—overstating benefit, avoiding prognostic clarity, or reaching for another line of treatment because the harder conversation feels out of reach. The taxonomy of overtreatment² documents the downstream consequences: moral distress, imposter syndrome, and burnout.

In preparing this editorial, our psycho-oncologist said plainly: ‘I can only truly enter into connection with a patient when I am in connection with myself—and that is not always the case. Certainly not in the last week before annual leave, and not when the mental load becomes too great’. This is not a failure of skill or commitment. It is the reality of emotional work under pressure. The capacity to stay present with a patient’s uncertainty—without deflecting into false reassurance or unnecessary intervention—depends on resources that must be actively protected. Reflective practice, Balint groups, and communication training are not soft extras.

They are burnout prophylaxis—and reading this article is itself a step in that direction, because understanding the framework of adaptive hope makes these conversations less threatening and more navigable.

An honest admission about interdisciplinarity

In oncology, ‘emotional work’ is also delegated—for example to the psycho-oncologist, yes to the oncology nurse, occasionally to the social worker, and—depending on the patient’s background—to the chaplain. This delegation is sometimes appropriate, but it can also become a way of avoiding discomfort that is, in fact, part of the oncologist’s own professional responsibility. Doctors early in their career often feel pressure to be simultaneously fully informative and emotionally sensitive, without the training or time to achieve either. These are systemic failures, not individual ones.

Cherny et al.¹ make a compelling case that managing hope and despair in serious illness requires a genuine multidisciplinary team—not as a coordination structure but as a shared clinical responsibility. No single clinician can address the physical, relational, cultural, spiritual, and existential dimensions of hope. The MDT is not just good practice here. It is the only realistic answer.

Why you should read this article

This article will not give you a new first-line regimen or a biomarker. What it will do—if you allow it—is give you language for conversations you have been conducting by instinct alone, validate the discomfort you feel when a patient requests treatment you know cannot help, and name a phenomenon you have witnessed many times without a framework to act upon. The article equips you with skills that you did not necessarily expect or perceive in yourself. As such, it is also, in a very practical sense, burnout prophylaxis: understanding adaptive hope makes the most demanding conversations in oncology more bearable—for your patients and for you.

What this article ultimately describes is a daily situation every oncologist knows: two people in a room, one of them facing something frightening, the other trying to help. This article offers guidance for navigating that room.